课题基金 / 基金详情

Microbial Genome Sequencing: Comparative Microbial Genome Analysis of the Human-Bacteroides Symbiosis

Microbial Genome Sequencing: Comparative Microbial Genome Analysis of the Human-Bacteroides Symbiosis
微生物基因组测序:人类-拟杆菌共生的比较微生物基因组分析
批准号:
0333284
负责人:
Jeffrey Gordon
金额:
$199.37万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-11-01 至 2007-10-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
圣路易斯华盛顿大学的杰弗里·I·戈登博士和理查德·K·威尔逊博士获得了一项拨款,用于对通常存在于人体肠道的细菌的DNA进行测序。成年人类是大量友好细菌的家园:总数超过了我们体内的人体细胞数量。肠道中的微生物数量最多(10-100万亿个生物体)。这个由500-1000个物种组成的群落的基因组中嵌入的细菌基因数量是人类基因组中基因数量的~100倍。这些细菌基因的产物提供了在我们自己的基因组中没有完全进化的基本代谢能力,包括分解否则无法消化的营养物质的能力。目前的基因组学革命提供了一个前所未有的机会来定义正常肠道细菌群落的组成部分如何调节人类出生后发育和成人生理的特征。这笔赠款的重点是一组被称为类杆菌的细菌,它们占人体肠道微生物总数的25%左右。将对类杆菌的几个成员的基因组进行测序,以确定它们是如何成为肠道微生物群落中如此成功的成员的,并确定它们对人类生物学的贡献。另一类细菌--真细菌的基因组将被测序,以确定成功共生体的共同特征。在进化上,真细菌与类杆菌相距遥远,但在人类肠道中也有突出的代表。促使这一分析的一个假设是,我们的细菌伙伴已经开发出合成新的化学实体的能力,这些新的化学实体有助于建立和维持它们的互利关系,而勘探这些化学物质,并表征它们的运作方式,将为保持我们的健康和活力提供新的方法。在像肠道这样一个动态的、人口密集的生态系统中,细菌物种之间的基因交换可以对细菌的进化和生理学(例如,抗生素耐药性的传播)产生重要影响。因此,研究肠道细菌的基因组提供了一个机会来解决一般问题,这些问题涉及环境如何影响物种的发展,它们在群落中灭绝的定义和意义,以及它们合作处理原本无法获得的营养的机制。研究共生体使用的分子策略来定义环境中的稀缺性,在资源有限的情况下管理对关键资源的访问,以及做出关于分享商品以确保社会稳定的决定,可能会产生对环境工程师、生态学家、经济学家、企业经理以及那些研究、组织甚至管理我们人类社区的人很重要的操作原则。
英文摘要
A grant has been awarded to Drs. Jeffrey I. Gordon and Richard K. Wilson of Washington University in St. Louis to sequence the DNA of bacteria that normally reside in the human intestine. The adult human is home to a vast number of friendly bacteria: the total number exceeds the number of human cells in our body. The largest collection of microbes resides in the intestine (10-100 trillion organisms). The number of bacterial genes embedded in the genomes of this community of 500-1000 species is ~100 times greater than the number of genes in our human genome. The products of these bacterial genes provide essential metabolic capacities not fully evolved in our own genome, including the ability to break down otherwise indigestible nutrients. The current revolution in genomics provides an unprecedented opportunity to define how components of the normal intestinal bacterial community modulate features of human postnatal development and adult physiology. This grant focuses on a group of bacteria known as Bacteroides that account for ~25% of the total microbial population in the human intestine. The genomes of several members of Bacteroides will be sequenced to determine how they have become such successful members of the gut microbial community and to define their contributions to human biology. The genome of a member of another group of bacteria, Eubacterium, evolutionarily distant from Bacteroides but also prominently represented in the human intestine, will be sequenced to identify features common to successful symbionts. One assumption prompting this analysis is that our bacterial partners have developed the capacity to synthesize novel chemical entities that help establish and sustain their mutually beneficial relationships, and that prospecting for these chemicals, and characterizing how they operate will suggest new ways to maintain our health and vigor. In a dynamic, densely populated ecosystem like the gut, exchange of genes between bacterial species can have important effects on bacterial evolution and physiology (e.g., propagation of antibiotic resistance). Therefore, studying the genomes of gut bacteria provides an opportunity to address general questions related to how environment affects development of species, the definition and meaning of their extinction within a community, and the mechanisms by which they cooperate to process otherwise inaccessible nutrients. Studying the molecular strategies employed by symbionts for defining scarcity in their environment, for managing access to crucial resources when they are limiting, and for making decisions about sharing goods to ensure societal stability may yield operating principles important to environmental engineers, ecologists, economists, business managers, and those who study, organize, and even govern our human communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于Pan-genome技术的沙门氏菌血清型特异性基因挖掘、功能分析及分子鉴定
  • 批准号:
    31360388
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2013
  • 负责人:
    余水静
  • 依托单位:
基于Genome mining技术研究抑制表皮葡萄球菌生物膜形成的次级代谢产物
  • 批准号:
    21242003
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2012
  • 负责人:
    昌军
  • 依托单位:
基于Pan-genome技术探究问号钩端螺旋体不同血清型致病性差异的遗传基础
  • 批准号:
    81171587
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    郭晓奎
  • 依托单位: